Trump, Tariffs and food and drug administration
Digest more
The Artificial Intelligence in Pharmaceutical Market is forecasted to skyrocket from USD 3.24 billion in 2024 to $65.83 ...
It is increasingly clear that pharmaceutical companies can live with President Trump’s tariffs. What the industry can’t live ...
The biopharmaceutical industry is responding to Trump’s call to put America first by announcing three major actions to lower ...
President Donald Trump is relying on drugmakers to lower U.S. prices on their own, but he might get less than he bargained ...
Analysts warn of price risks even as generics, U.S. facilities, and European caps could blunt the impact.
If it can bounce back and generate solid returns in the next five years, now is about as good a time as any to invest in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback